Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuhe Keli (舒和颗粒) appears to be a non-specific or informal name for a Traditional Chinese Medicine (TCM) granule. Information gathered suggests it is likely related to formulations such as Piwei Shu Keli (脾胃舒颗粒) or Siwei Piwei Shu Keli (四味脾胃舒颗粒). These granules are typically composed of traditional Chinese herbs like Fuling (茯苓), Jishiteng (鸡矢藤), Shanzha (山楂), and Chenpi (陈皮). The primary function of such formulations is to strengthen the spleen and harmonize the stomach (健脾和胃), aid digestion, and relieve pain (消食止痛). They are commonly indicated for conditions arising from spleen and stomach deficiency, such as loss of appetite, abdominal distension and pain, and diarrhea. Fuling is known for enhancing immunity and liver protection, Shanzha for promoting digestion, and Chenpi for treating indigestion and cough with phlegm. The granules are administered orally after being dissolved in boiling water. Contraindications include diabetes patients due to sucrose content, and pregnant women should use them with caution. Patients are advised to avoid cold, raw, spicy, and greasy foods during treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuhe Keli.